Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Investigation of PEMF Therapy for Female Patients With IC/BPS

NCT: NCT05149573 · RECRUITING

NCT IDNCT05149573
StatusRECRUITING
Start Date2022-08-29
Completion2027-02

Brief Summary

The purpose of this study is to gather information about the safety and effectiveness of the non-pharmacological (non-drug), non-invasive treatment known as low-frequency pulsed electromagnetic field (PEMF) therapy. The study team will distribute the PEMF device to female adults with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) to measure its ability to decrease bladder and pelvic pain as well as other urinary symptoms associated with IC/BPS. There are two sequential Aims in this study and subjects will be recruited to participate in only one Aim. In both Aims, data will be collected at baseline/enrollment, 4-weeks after using PEMF therapy, and 8, 12, and 16 weeks post-enrollment.

Frequently Asked Questions

What is Investigation of PEMF Therapy for Female Patients With IC/BPS?

Investigation of PEMF Therapy for Female Patients With IC/BPS is a clinical trial registered under NCT05149573. Current status: RECRUITING.

What is the status of NCT05149573?

The current status of NCT05149573 (Investigation of PEMF Therapy for Female Patients With IC/BPS) is: RECRUITING.

When did Investigation of PEMF Therapy for Female Patients With IC/BPS start?

Investigation of PEMF Therapy for Female Patients With IC/BPS started on 2022-08-29.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.